MIPI Insider Trading Activity and SEC Form 4 Filings
MIPI insider trading summary
No open-market insider purchases or sales of Molecular Insight Pharmaceuticals, Inc. (MIPI) have been reported on SEC Form 4 in the past 12 months.
Latest MIPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 28, 2011 | David S Barlow | 10% Owner | Sell | $2K (9,000 @ $0.17) |
| Jan 28, 2011 | David S Barlow | 10% Owner | Sell | $960 (6,000 @ $0.16) |
| Jan 28, 2011 | David S Barlow | 10% Owner | Sell | $846 (6,000 @ $0.14) |
| Jan 28, 2011 | David S Barlow | 10% Owner | Sell | $4K (21,000 @ $0.17) |
| Jan 28, 2011 | David S Barlow | 10% Owner | Sell | $3K (17,000 @ $0.15) |
| Jan 27, 2011 | David S Barlow | 10% Owner | Sell | $6K (33,000 @ $0.17) |
| Jan 27, 2011 | David S Barlow | 10% Owner | Sell | $900 (5,000 @ $0.18) |
| Dec 17, 2010 | David S Barlow | 10% Owner | Sell | $420 (2,000 @ $0.21) |
| Dec 17, 2010 | David S Barlow | 10% Owner | Sell | $24K (122,000 @ $0.20) |
| Dec 17, 2010 | David S Barlow | 10% Owner | Sell | $6K (31,000 @ $0.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.